Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
A Novel PEtOx-Based Nanogel Targeting Prostate Cancer Cells for Drug Delivery
Download
Macromolecular Bioscience - 2023 - G ly z - A Novel PEtOx‐Based Nanogel Targeting Prostate Cancer Cells for Drug Delivery.pdf
Date
2023-01-01
Author
Gülyüz, Sevgi
SESSEVMEZ, Melike
Ukuser, Gokcen
Khalily, Melek Parlak
Tiryaki, Selen
Sipahioglu, Tarik
Birgül, Kaan
Ömeroğlu, İpek
Özçubukçu, Salih
Telci, Dilek
Küçükgüzel, Ş. Güniz
Durmuş, Mahmut
Cevher, Erdal
Yılmaz, Özgür
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
25
views
31
downloads
Cite This
This study focuses on creating a specialized nanogel for targeted drug delivery in cancer treatment, specifically targeting prostate cancer. This nanogel (referred to as SGK 636/Peptide 563/PEtOx nanogel) is created using hydrophilic poly(2-ethyl-2-oxazoline) (PEtOx) through a combination of living/cationic ring-opening polymerization (CROP) and alkyne-azide cycloaddition (CuAAC) “click” chemical reactions. A fluorescent probe (BODIPY) is also conjugated with the nanogel to monitor drug delivery. The characterizations through 1H-NMR, and FT-IR, SEM, TEM, and DLS confirm the successful production of uniform, and spherical nanogels with controllable sizes (100 to 296 nm) and stability in physiological conditions. The biocompatibility of nanogels is evaluated using MTT cytotoxicity assays, revealing dose-dependent cytotoxicity. Drug-loaded nanogels exhibited significantly higher cytotoxicity against cancer cells in vitro compared to drug-free nanogels. Targeting efficiency is examined using both peptide-conjugated and peptide-free nanogels, with the intracellular uptake of peptide 563-conjugated nanogels by tumor cells being 60-fold higher than that of nanogels without the peptide. The findings suggest that the prepared nanogel holds great potential for various drug delivery applications due to its ease of synthesis, tunable functionality, non-toxicity, and enhanced intracellular uptake in the tumor region.
Subject Keywords
CuAAC click chemistry
,
cytotoxicity
,
nanogels
,
peptide
,
prostate cancer
,
star poly(2-ethyl-2-oxazoline)
,
targeted drug delivery
URI
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85174516340&origin=inward
https://hdl.handle.net/11511/106128
Journal
Macromolecular Bioscience
DOI
https://doi.org/10.1002/mabi.202300324
Collections
Department of Chemistry, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
S. Gülyüz et al., “A Novel PEtOx-Based Nanogel Targeting Prostate Cancer Cells for Drug Delivery,”
Macromolecular Bioscience
, pp. 0–0, 2023, Accessed: 00, 2023. [Online]. Available: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85174516340&origin=inward.